Skip navigation

Regeneron Pharmaceuticals Inc.

NMS : REGN
Pharmaceuticals
Tarrytown NY
2013 Revenue (US$ Millions)$2,105
2012 Revenue (US$ Millions)$1,378
Revenue Growth (%)52.69%
Net Income (US$ Millions)$424
Common Shares Outstanding (Millions)$100
Earnings Per Share (US$)$3.81
Price To Earnings Ratio316.63
Total Equity (US$ Millions)$1,952
Profit Margin (%)20.16%
Return On Equity (%)34.07%
Long Term Debt (US$ Millions)$505
Debt To Equity Ratio (%)0.26%
Market Capitalization (US$ Millions)$27,438
Total Assets (US$ Millions)$2,951
Return on Assets (%)20.4
Current Assets (US$ Millions)$1,797
Inventories (US$ Millions)$70
Current Liabilities (US$ Millions)$299
Cost of Goods Sold (US$ Millions)$155
Asset Turnover0.71
Inventory TurnoverN/A
ExchangeNMS